@article{3172317,
    title = "No Differences in Molecular Relapse-Free Survival after Stopping
Imatinib Treatment of Chronic Myeloid Leukemia Between Patients with
Prior 4.5 Log Reduction (MR4.5) but Detectable and Patients with
Undetectable Disease in the EURO-SKI Trial",
    author = "Pfirrmann, Markus and Mahon, Francois-Xavier and Guilhot, Joelle and and Richter, Johan and Almeida, Antonio and Janssen, Jeroen J. W. M. and and Mayer, Jiri and Porkka, Kimmo and Panayiotidis, Panayiotis and and Olsson-Stromberg, Ulla and Berger, Marc G. and Diamond, Joana and and Ehrencrona, Hans and Kairisto, Veli and Polakova, Katerina Machova and and Muller, Martin C. and Mustjoki, Satu and Hochhaus, Andreas and Saussele, and Susanne and Hjorth-Hansen, Henrik",
    journal = "Blood advances",
    year = "2016",
    volume = "128",
    number = "22",
    publisher = "AMER SOC HEMATOLOGY",
    doi = "10.1182/blood.V128.22.789.789"
}